CGRP Monoclonal Antibody use for the Preventive Treatment of Refractory Headache Disorders in Adolescents.

BACKGROUND: Monoclonal antibodies (mAbs) to calcitonin gene-related peptide (CGRP) or its receptor have clinical trial evidence in adults with headache, but data are lacking in adolescents. OBJECTIVE: To describe the safety and efficacy of CGRP monoclonal antibody (mAb) treatment in adolescents with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatr Neurol
Egile Nagusiak: Greene, Kaitlin A., Gentile, Carlyn Patterson, Szperka, Christina L., Yonker, Marcy, Gelfand, Amy A., Grimes, Barbara, Irwin, Samantha L.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7770043/
https://ncbi.nlm.nih.gov/pubmed/33232919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pediatrneurol.2020.09.014
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak